A 0 8 (Mirtazapine 15 mg)
Pill with imprint A 0 8 is Yellow, Capsule-shape and has been identified as Mirtazapine 15 mg. It is supplied by Aurobindo Pharma.
Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A 0 8
Mirtazapine
- Imprint:
- A 0 8
- Strength:
- 15 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma
- Inactive Ingredients:
-
- corn starch
- low substituted hydroxypropyl cellulose
- magnesium stearate
- silicon dioxide
- lactose monohydrate
- hypromellose 2910 (6 mPa.s)
- titanium dioxide
- hydroxypropyl cellulose (type h)
- ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0031 | Aurobindo Pharma Limited |
| 13107-0031 | Aurobindo Pharma Limited |
| 68084-0119 | Amerisource Health Services |
More about mirtazapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1166 Reviews
- Drug class: tetracyclic antidepressants
- FDA Alerts (3)
Consumer resources
- Mirtazapine
- Mirtazapine Orally Disintegrating Tablets
- Mirtazapine Tablets
- Mirtazapine (Advanced Reading)
Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
